CR Stock Analysis: Crane | NYSE

Aerospace Systems, Process Valves, Pumps, Sensors

Total Rating 58

Safety 84

Buy Signal 0.05

Specialty Industrial Machinery
Industry Rotation: +6.4

Market Cap: 11.8B
Avg Turnover: 76.6M

Risk 3d forecast

Volatility32.5%

VaR 5^th Pctl5.36%

VaR vs Median0.24%

Reward TTM

Sharpe Ratio0.40

Rel. Str. IBD49

Rel. Str. Peer Group55.3

Character TTM

Beta1.282

Beta Downside1.201

Hurst Exponent0.598

Drawdowns 3y

Max DD28.02%

CAGR/Max DD1.18

CAGR/Mean DD5.26

EPS (Earnings per Share)

EPS CAGR: 14.57%
EPS Trend: 82.5%

Last SUE: 2.33
Qual. Beats: 5

Revenue

Rev. CAGR: 11.88%
Rev. Trend: 90.8%

Last SUE: 1.77
Qual. Beats: 2

Warnings

Below Avwap Earnings

Tailwinds

Confidence

Seasonality 3.5 years of data

Jan +4.5% 0

Feb +0.8% 0

Mar -5.7% 13

Apr +2.0% 13

May +1.2% 32

Jun +8.1% 13

Jul +1.6% 13

Aug -6.6% 45

Sep -3.7% 32

Oct -2.4% 0

Nov +3.0% 0

Dec -10.0% 29

How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.

Description: CR Crane

Crane Company (NYSE: CR) is a U.S.-based industrial manufacturer founded in 1855 and headquartered in Stamford, Connecticut. The company operates two business segments: Aerospace & Advanced Technologies and Process Flow Technologies, serving customers in the United States, Canada, the United Kingdom, Continental Europe, and other international markets.

The Aerospace & Advanced Technologies segment supplies OEM and aftermarket components for commercial aerospace, military aerospace, defense, and space markets, including pressure sensors, aircraft braking systems, power conversion solutions, and lubrication systems. The Process Flow Technologies segment manufactures process valves, pumps, valve positioning and control systems, vacuum insulated pipe systems, and valve diagnostic and calibration equipment for industrial customers.

CR became an independent publicly traded company following its 2023 spin-off, operating as a focused industrial components supplier rather than a diversified conglomerate. Its business model spans two distinct end markets - aerospace/defense and industrial process flow - which serve as separate economic cycles, providing some diversification across commercial aviation, defense spending, and industrial capital investment.

Headlines to Watch Out For

Commercial aerospace aftermarket recovery drives Aerospace segment margin expansion
Process Flow Technologies order growth reflects chemical and energy capex rebound
Separation from Crane NXT sharpens investor focus on industrial pure-play

Piotroski VR-10 (Strict) 4.5

Net Income: 336.1m TTM > 0 and > 6% of Revenue
FCF/TA: 0.07 > 0.02 and ΔFCF/TA -4.93 > 1.0
NWC/Revenue: 36.73% < 20% (prev 36.03%; Δ 0.70% < -1%)
CFO/TA 0.08 > 3% & CFO 328.9m > Net Income 336.1m
Net Debt (843.1m) to EBITDA (558.2m): 1.51 < 3
Current Ratio: 2.80 > 1.5 & < 3
Outstanding Shares: last quarter (58.7m) vs 12m ago 0.34% < -2%
Gross Margin: 41.74% > 18% (prev 41.32%; Δ 0.43% > 0.5%)
Asset Turnover: 79.16% > 50% (prev 90.44%; Δ -11.29% > 0%)
Interest Coverage Ratio: 13.32 > 6 (EBIT TTM 478.1m / Interest Expense TTM 35.9m)

Altman Z'' 5.11

A: 0.24 (Total Current Assets 1.48b - Total Current Liabilities 527.5m) / Total Assets 4.03b
B: 0.41 (Retained Earnings 1.67b / Total Assets 4.03b)
C: 0.15 (EBIT TTM 478.1m / Avg Total Assets 3.27b)
D: 1.18 (Book Value of Equity 2.18b / Total Liabilities 1.85b)
Altman-Z'' = 5.11 = AAA

Beneish M -2.78

DSRI: 0.93 (Receivables 487.6m/460.1m, Revenue 2.59b/2.28b)
GMI: 0.99 (GM 41.32% / 41.74%)
AQI: 1.36 (AQ_t 0.54 / AQ_t-1 0.40)
SGI: 1.14 (Revenue 2.59b / 2.28b)
TATA: 0.00 (NI 336.1m - CFO 328.9m) / TA 4.03b)
Beneish M = -2.78 (Cap -4..+1) = A

What is the price of CR shares?

As of October 09, 2026, the stock is trading at USD 202.12 with a total of 238,766 shares traded. Over the past week, the price has changed by -2.04%, over one month by -0.26%, over three months by -5.49% and over the past year by +12.61%.

Current recommended Stop Loss: 190.80 (which is 5.6% or 2.1 ATR below the current price).

Is CR a buy, sell or hold?

Crane has received a consensus analysts rating of 4.70. Therefore, it is recommended to buy CR.

StrongBuy: 8
Buy: 1
Hold: 1
Sell: 0
StrongSell: 0

What are the forecasts/targets for the CR price?

Analysts Target Price	237.2	17.4%

Crane (CR) - Fundamental Data Overview as of 09 October 2026

Market Cap USD = 11.8b (11.8b USD * 1.0 USD.USD)
P/E Trailing = 36.4785
P/E Forward = 26.178
P/S = 4.5403
P/B = 5.4236
P/EG = 2.3153
Revenue TTM = 2.59b USD
EBIT TTM = 478.1m USD
EBITDA TTM = 558.2m USD
Long Term Debt = 1.15b USD (from longTermDebt, last fiscal year)
Short Term Debt = 28.6m USD (from shortTermDebt, last quarter)
Debt = 1.19b USD (corrected: LT Debt 1.15b + ST Debt 28.6m) + Leases 16.7m
Net Debt = 843.1m USD (calculated: Debt 1.19b - CCE 350.4m)
Enterprise Value = 12.6b USD (11.8b + Debt 1.19b - CCE 350.4m)
Interest Coverage Ratio = 13.32 (Ebit TTM 478.1m / Interest Expense TTM 35.9m)
EV/FCF = 44.97x (Enterprise Value 12.6b / FCF TTM 280.4m)
FCF Yield = 2.22% (FCF TTM 280.4m / Enterprise Value 12.6b)
FCF Margin = 10.82% (FCF TTM 280.4m / Revenue TTM 2.59b)
Net Margin = 12.97% (Net Income TTM 336.1m / Revenue TTM 2.59b)
Gross Margin = 41.74% ((Revenue TTM 2.59b - Cost of Revenue TTM 1.51b) / Revenue TTM)
Gross Margin QoQ = 42.43% (prev 40.39%)
Tobins Q-Ratio = 3.13 (Enterprise Value 12.6b / Total Assets 4.03b)
Interest Expense / Debt = 3.01% (Interest Expense 35.9m / Debt 1.19b)
Taxrate = 24.05% (106.4m / 442.5m)
NOPAT = 363.1m (EBIT 478.1m * (1 - 24.05%))
Current Ratio = 2.80 (Total Current Assets 1.48b / Total Current Liabilities 527.5m)
Debt / Equity = 0.55 (Debt 1.19b / totalStockholderEquity, last quarter 2.18b)
Debt / EBITDA = 1.51 (Net Debt 843.1m / EBITDA 558.2m)
Debt / FCF = 3.01 (Net Debt 843.1m / FCF TTM 280.4m)
Total Stockholder Equity = 2.08b (last 4 quarters mean from totalStockholderEquity)
RoA = 10.27% (Net Income 336.1m / Total Assets 4.03b)
RoE = 16.19% (Net Income TTM 336.1m / Total Stockholder Equity 2.08b)
RoCE = 14.83% (EBIT 478.1m / Capital Employed (Equity 2.08b + L.T.Debt 1.15b))
RoIC = 10.67% (NOPAT 363.1m / Invested Capital 3.40b)
WACC = 9.73% (E(11.8b)/V(13.0b) * Re(10.49%) + D(1.19b)/V(13.0b) * Rd(3.01%) * (1-Tc(0.24)))
Discount Rate = 10.49% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 78.54 | Cagr: 0.46%
[DCF] Terminal Value 69.73% ; FCFF base≈287.9m ; Y1≈273.9m ; Y5≈260.6m
[DCF] Fair Price = 42.98 (EV 3.33b - Net Debt 843.1m = Equity 2.48b / Shares 57.8m; r=9.73% [WACC]; 5y FCF grow -6.25% → 2.50% )
EPS Correlation: 82.53 | EPS CAGR: 14.57% | SUE: 2.33 | # QB: 5
Revenue Correlation: 90.78 | Revenue CAGR: 11.88% | SUE: 1.77 | # QB: 2
EPS current Quarter (2026-09-30): EPS=1.81 | Chg30d=+0.43% | Revisions=+40% | Analysts=9
EPS current Year (2026-12-31): EPS=7.02 | Chg30d=+0.14% | Revisions=+40% | GrowthEPS=+16.0% | GrowthRev=+25.4%
EPS next Year (2027-12-31): EPS=7.83 | Chg30d=+0.13% | Revisions=+40% | GrowthEPS=+11.6% | GrowthRev=+5.5%
[Analyst] Revisions Ratio: +67% (up=6, down=0)